Detalhe da pesquisa
1.
H396P mutation in chronic myeloid leukaemia patient on nilotinib - A case report.
Malays J Pathol
; 43(1): 63-68, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33903307
2.
Early relapse after complete remission of primary plasma cell leukaemia manifesting clonal evolution: A case report.
Malays J Pathol
; 42(1): 143-150, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32342945
3.
FISH versus real-time quantitative PCR for monitoring of minimal residual disease in chronic myeloid leukaemia patients on tyrosine kinase inhibitor therapy.
Malays J Pathol
; 41(2): 149-160, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31427550
4.
Myelodysplastic syndrome with fibrosis and complex karyotype arising in a patient with essential thrombocythaemia.
Malays J Pathol
; 40(2): 191-197, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30173238
5.
Primary imatinib resistance in chronic myeloid leukemia patients in a developing country: BCR-ABL kinase domain mutations or BCR-ABL independent mechanisms?
Malays J Pathol
; 39(2): 107-113, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28866691
6.
POEMS syndrome.
Malays J Pathol
; 39(3): 297-303, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29279594
7.
Rituximab-induced lung disease.
Med J Malaysia
; 71(4): 209-210, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27770123
8.
NK/T cell lymphoma associated with peripheral eosinophilia.
Malays J Pathol
; 36(3): 201-5, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25500520
9.
MicroRNAs that affect the Fanconi Anemia/BRCA pathway are downregulated in imatinib-resistant chronic myeloid leukemia patients without detectable BCR-ABL kinase domain mutations.
Leuk Res
; 59: 32-40, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28544907